Purpose: To identify the efficacy and barriers that patients face concerning treatment of opiate addiction with buprenorphine and naloxone (Suboxone) through an examination of current peer reviewed literature comparing buprenorphine and naloxone to that of methadone and the barriers to treatment.Conclusions: Access to treatment, social stigma, and overall treatment costs are primary barriers to persons with opiate addictions seeking treatment. Buprenorphine and naloxone treatment offers equal efficacy to the standard treatment of methadone, with pharmacologic advantages, lower cost with office-based treatment, and increased access to those seeking addiction management without the need to attend a methadone clinic and avoid the stigma associated with opioid addiction.
Implications for Practice: More research is required to examine long-term outcomes with buprenorphine and naloxone managed addiction treatment. Currently, this treatment is only available through qualified physicians, hindering access to care. Allowing nurse practitioners to have prescriptive authority would increase access to treatment for addicts in an office-based setting.
Metrics
31 File views/ downloads
99 Record Views
Details
Title
Buprenorphine and Naloxone (Suboxone) Efficacy Compared With Methadone and Challenges in Treating Opiate Addiction
Creators
Todd M. Carpenter
Contributors
Lorna Schumann (Advisor)
Awarding Institution
Washington State University
Academic Unit
Research Projects, College of Nursing
Theses and Dissertations
Master of Nursing (MN), Washington State University
Publisher
Washington State University; Spokane, Washington
Identifiers
99900590540101842
Copyright
http://creativecommons.org/licenses/by-nd/3.0/us/; Creative Commons Attribution-NoDerivs 3.0 United States (CC BY-ND 3.0 US)